Circulating Tumor DNA as a Biomarker of Progression in Colorectal Cancer

home / between-the-lines / circulating-tumor-dna-as-a-biomarker-of-progression-in-colorectal-cancer

Drs Liliana Bustamante and Richard Kim review “Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases,” and consider how to apply the paper’s findings into clinical practice.